Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Gross Margin (2020 - 2025)

Historic Gross Margin for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 67.96%.

  • Bioventus' Gross Margin rose 6400.0% to 67.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.76%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 67.72% for FY2024, which is 36600.0% up from last year.
  • Per Bioventus' latest filing, its Gross Margin stood at 67.96% for Q3 2025, which was up 6400.0% from 69.14% recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Gross Margin peaked at 72.83% during Q2 2021, and registered a low of 58.96% during Q4 2022.
  • Over the past 5 years, Bioventus' median Gross Margin value was 67.3% (recorded in 2021), while the average stood at 66.92%.
  • Per our database at Business Quant, Bioventus' Gross Margin tumbled by -83400bps in 2022 and then skyrocketed by 61800bps in 2024.
  • Over the past 5 years, Bioventus' Gross Margin (Quarter) stood at 67.3% in 2021, then dropped by -12bps to 58.96% in 2022, then rose by 8bps to 63.73% in 2023, then increased by 5bps to 66.82% in 2024, then increased by 2bps to 67.96% in 2025.
  • Its Gross Margin was 67.96% in Q3 2025, compared to 69.14% in Q2 2025 and 67.05% in Q1 2025.